Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Suspended × netrin-1 inhibitor NP137 × 1 year × Clear all

Phase

Status

Suspended 1 Not yet recruiting 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Hepatocellular 1

Interventions

Specimen Handling 31 Magnetic Resonance Spectroscopy 20 Biopsy 15 Cyclophosphamide 13 Vincristine 7 Nivolumab 6 Doxorubicin 6 Bevacizumab 6 pembrolizumab 5 Prednisone 5 Etoposide 5 Cisplatin 5 venetoclax 4 fludarabine 4 durvalumab 4 atezolizumab 4 Rituximab 4 Radiosurgery 4 Radiation 4 Lenalidomide 4 Ipilimumab 4 Carboplatin 4 prednylidene 3 fludarabine phosphate 3 deltacortene 3 X-Rays 3 Surveys and Questionnaires 3 Educational Status 3 Dexamethasone 3 Cytarabine 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05546879 2026-02-10

Liver-NET1

University Hospital, Grenoble

Phase 1 Suspended

Gastrointestinal

Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon ⚡